Cargando…
Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions
BACKGROUND: Combining targeted biopsy (TB) with systematic biopsy (SB) is currently recommended as the first-line biopsy method by the European Association of Urology (EAU) guidelines in patients diagnosed with prostate cancer (PCa) with an abnormal magnetic resonance imaging (MRI). The combined SB...
Autores principales: | Wang, Fei, Chen, Tong, Wang, Meng, Chen, Hanbing, Wang, Caishan, Liu, Peiqing, Liu, Songtao, Luo, Jing, Ma, Qi, Xu, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697444/ https://www.ncbi.nlm.nih.gov/pubmed/34949183 http://dx.doi.org/10.1186/s12894-021-00949-7 |
Ejemplares similares
-
Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022) -
Diagnostic significance of urinary long non-coding PCA3 RNA in prostate cancer
por: Wang, Tao, et al.
Publicado: (2017) -
Extraction of Prostatic Lumina and Automated Recognition for Prostatic Calculus Image Using PCA-SVM
por: Wang, Zhuocai, et al.
Publicado: (2011) -
Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
por: Jeet, Varinder, et al.
Publicado: (2014) -
PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
por: Ruffion, Alain, et al.
Publicado: (2013)